title: Depo-Provera: just another contraceptive?
mesh_terms: D000568:Amenorrhea; D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D004194:Disease; D004739:England; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006470:Hemorrhage; D007267:Injections; D007878:Legislation as Topic; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D008796:Metrorrhagia; D009369:Neoplasms; D009656:North America; D012816:Signs and Symptoms; D006113:United Kingdom; D014481:United States
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
keywords: Amenorrhea; Americas; Bleeding; Cancer; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Depo-provera--side effects; Developed Countries; Diseases; England; Europe; Family Planning; Injectables; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Metrorrhagia; Neoplasms; North America; Northern America; Northern Europe; Population Law; Signs And Symptoms; Theoretical Effectiveness; United Kingdom; United States